12. Advanced Anti-Aging Drugs

Rapamycin and metformin are two drugs under investigation for their potential to extend lifespan and healthspan. Rapamycin, an mTOR inhibitor, has demonstrated lifespan extension in animal models by promoting autophagy and reducing age-related diseases. Metformin, commonly used to treat type 2 diabetes, has shown promise in extending healthspan and lifespan in mice. Clinical trials, such as the Targeting Aging with Metformin (TAME) study, are underway to assess their effects on aging in humans. (pharmaceutical-journal.com)